Patent details

EP3351269 Title: SELF-BUFFERING PROTEIN FORMULATIONS

Basic Information

Publication number:
EP3351269
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP172057341
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SELF-BUFFERING PROTEIN FORMULATIONS
French Title of Invention:
FORMULATIONS DE PROTÉINE À TAMPONNAGE SPONTANÉ
German Title of Invention:
SELBSTPUFFERNDE PROTEINFORMULIERUNGEN
SPC Number:

Dates

Filing date:
08/06/2006
Grant date:
29/01/2020
EP Publication Date:
25/07/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/01/2020
EP B1 Publication Date:
29/01/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2020
Expiration date:
08/06/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/01/2020
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:
REMMELE, Richard, Louis, Jr.
Address:
United States (US)

2

Name:
HERSHENSON, Susan, Irene
Address:
United States (US)

3

Name:
KRAS, Eva
Address:
United States (US)

4

Name:
BREMS, David, N.
Address:
United States (US)

5

Name:
GOKARN, Yatin, R.
Address:
United States (US)

Priority

Priority Number:
690582 P
Priority Date:
14/06/2005
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/08; A61K 39/395; C12P 21/08;

Publication

European Patent Bulletin

Issue number:
202005
Publication date:
29/01/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages